{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:25:06Z","timestamp":1776770706215,"version":"3.51.2"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.plipres.2014.07.003","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T15:00:31Z","timestamp":1407337231000},"page":"36-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Understanding high-density lipoprotein function in disease: Recent advances in proteomics unravel the complexity of its composition and biology"],"prefix":"10.1016","volume":"56","author":[{"given":"Ruth","family":"Birner-Gruenberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schittmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Holzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunther","family":"Marsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.plipres.2014.07.003_b0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/14789450.5.1.91","article-title":"Elucidation of lipoprotein particles structure by proteomic analysis","volume":"5","author":"Alonzi","year":"2008","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.plipres.2014.07.003_b0010","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2014.07.003_b0015","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2014.07.003_b0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0021-9150(03)00006-6","article-title":"High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions","volume":"168","author":"Barter","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2014.07.003_b0025","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.plipres.2014.07.003_b0030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jacl.2013.08.001","article-title":"High-density lipoproteins: a consensus statement from the National Lipid Association","volume":"7","author":"Toth","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.plipres.2014.07.003_b0035","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/CIRCULATIONAHA.113.000962","article-title":"Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges","volume":"128","author":"Rosenson","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2014.07.003_b0040","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1194\/jlr.R035725","article-title":"Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond","volume":"54","author":"Shah","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0045","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1194\/jlr.R036095","article-title":"Unraveling the complexities of the HDL lipidome","volume":"54","author":"Kontush","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pharmthera.2012.12.001","article-title":"Inflammation alters HDL composition and function: implications for HDL-raising therapies","volume":"137","author":"Marsche","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.plipres.2014.07.003_b0055","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0060","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.ATV.0000057572.97137.DD","article-title":"Importance of different pathways of cellular cholesterol efflux","volume":"23","author":"Yancey","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0065","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/387414a0","article-title":"Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels","volume":"387","author":"Kozarsky","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2014.07.003_b0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.RES.0000185320.82962.F7","article-title":"Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation","volume":"97","author":"Moore","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0075","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1073\/pnas.91.20.9607","article-title":"Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse","volume":"91","author":"Plump","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.plipres.2014.07.003_b0080","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI117412","article-title":"Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice","volume":"94","author":"Paszty","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0085","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1161\/01.CIR.100.17.1816","article-title":"Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice","volume":"100","author":"Tangirala","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2014.07.003_b0090","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.297.15.jpc70004","article-title":"Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial","volume":"297","author":"Tardif","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.plipres.2014.07.003_b0095","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial","volume":"290","author":"Nissen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.plipres.2014.07.003_b0100","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.jacc.2009.12.067","article-title":"A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome","volume":"55","author":"Waksman","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2014.07.003_b0105","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.108.182063","article-title":"Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque","volume":"103","author":"Shaw","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cmet.2008.03.001","article-title":"HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis","volume":"7","author":"Tall","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.plipres.2014.07.003_b0115","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1172\/JCI14011","article-title":"Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems","volume":"108","author":"Krieger","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0120","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cmet.2013.04.002","article-title":"Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL","volume":"17","author":"Lim","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.plipres.2014.07.003_b0125","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI63685","article-title":"Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice","volume":"123","author":"Martel","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0130","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1194\/jlr.M022194","article-title":"Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein","volume":"53","author":"Vrins","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa0907687","article-title":"Genetic variant of the scavenger receptor BI in humans","volume":"364","author":"Vergeer","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plipres.2014.07.003_b0140","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Antiinflammatory properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/iub.588","article-title":"Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation","volume":"64","author":"Hine","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.plipres.2014.07.003_b0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MOL.0b013e32833bcdc1","article-title":"Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities","volume":"21","author":"Kontush","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2014.07.003_b0155","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"Cockerill","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCRESAHA.114.300738","article-title":"ATP-binding cassette transporters, atherosclerosis, and inflammation","volume":"114","author":"Westerterp","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0165","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1161\/ATVBAHA.112.300134","article-title":"Cholesterol efflux: a novel regulator of myelopoiesis and atherogenesis","volume":"32","author":"Tall","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0170","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.113.301086","article-title":"Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice","volume":"112","author":"Westerterp","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0175","doi-asserted-by":"crossref","first-page":"22930","DOI":"10.1074\/jbc.M801408200","article-title":"Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages","volume":"283","author":"Zhu","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0180","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.108.793869","article-title":"Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions","volume":"118","author":"Yvan-Charvet","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2014.07.003_b0185","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/ATVBAHA.109.199166","article-title":"ABCG1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions","volume":"30","author":"Whetzel","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0190","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"De Nardo","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.plipres.2014.07.003_b0195","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200418004","article-title":"HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3","volume":"113","author":"Nofer","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0200","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/89986","article-title":"High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase","volume":"7","author":"Yuhanna","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.plipres.2014.07.003_b0205","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1074\/jbc.M211394200","article-title":"High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases","volume":"278","author":"Mineo","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0210","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1172\/JCI35470","article-title":"ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet","volume":"118","author":"Terasaka","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/bbrc.1997.7236","article-title":"Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins","volume":"238","author":"Calabresi","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2014.07.003_b0220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0021-9150(03)00097-2","article-title":"Adhesion molecules and atherosclerosis","volume":"170","author":"Blankenberg","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2014.07.003_b0225","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jacc.2011.08.030","article-title":"The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease","volume":"58","author":"Patel","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2014.07.003_b0230","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1073\/pnas.1016086108","article-title":"HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells","volume":"108","author":"Feig","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.plipres.2014.07.003_b0235","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/ATVBAHA.109.198226","article-title":"Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome","volume":"30","author":"Julve","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0240","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCRESAHA.113.301684","article-title":"Exercise training in patients with chronic heart failure promotes restoration of high-density lipoprotein functional properties","volume":"113","author":"Adams","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0245","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0250","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/ars.2011.4403","article-title":"Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: novel pathways generating dysfunctional high-density lipoprotein","volume":"17","author":"Holzer","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.plipres.2014.07.003_b0255","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/emmm.201200224","article-title":"Molecular mechanisms of vascular effects of high-density lipoprotein: alterations in cardiovascular disease","volume":"4","author":"Besler","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.plipres.2014.07.003_b0260","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.ATV.0000148703.43429.25","article-title":"2-Chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis","volume":"24","author":"Marsche","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0265","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/CIRCRESAHA.111.258673","article-title":"Novel biological functions of high-density lipoprotein cholesterol","volume":"111","author":"Mineo","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCRESAHA.114.300935","article-title":"High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target","volume":"114","author":"Luscher","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0275","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/01.ATV.17.10.2158","article-title":"HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL","volume":"17","author":"Suc","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0280","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.112.108753","article-title":"Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling","volume":"127","author":"Riwanto","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2014.07.003_b0285","doi-asserted-by":"crossref","first-page":"34480","DOI":"10.1074\/jbc.M103782200","article-title":"Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids","volume":"276","author":"Nofer","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0290","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.114.300760","article-title":"High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies","volume":"114","author":"Feig","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0295","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/CIRCRESAHA.112.280958","article-title":"HDL and cardiovascular risk: time to call the plumber?","volume":"111","author":"Hewing","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0300","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2014.07.003_b0305","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1093\/eurheartj\/eht343","article-title":"High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality","volume":"34","author":"Silbernagel","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.plipres.2014.07.003_b0310","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2008.03.016","article-title":"Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches","volume":"51","author":"deGoma","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2014.07.003_b0315","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1253\/circj.CJ-13-1025","article-title":"High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis","volume":"77","author":"Annema","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.plipres.2014.07.003_b0320","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/bmm.13.35","article-title":"Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research","volume":"7","author":"Triolo","year":"2013","journal-title":"Biomark Med"},{"key":"10.1016\/j.plipres.2014.07.003_b0325","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1172\/JCI25327","article-title":"Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo","volume":"115","author":"Zhang","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0330","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.jacc.2013.07.025","article-title":"The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality","volume":"62","author":"Khera","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2014.07.003_b0335","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jacl.2008.12.003","article-title":"Extended-release niacin reduces LDL particle number without changing total LDL cholesterol in patients with stable CAD","volume":"3","author":"Jafri","year":"2009","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.plipres.2014.07.003_b0340","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis)","volume":"60","author":"Mackey","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.plipres.2014.07.003_b0345","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1161\/CIRCULATIONAHA.113.002624","article-title":"Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma","volume":"128","author":"DiDonato","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2014.07.003_b0350","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nm.3459","article-title":"An abundant dysfunctional apolipoprotein A1 in human atheroma","volume":"20","author":"Huang","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.plipres.2014.07.003_b0355","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1089\/ars.2010.3640","article-title":"Protein carbamylation renders high-density lipoprotein dysfunctional","volume":"14","author":"Holzer","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.plipres.2014.07.003_b0360","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0365","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cvr\/cvs089","article-title":"High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A","volume":"94","author":"Tolle","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0370","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2011070668","article-title":"Serum amyloid A in uremic HDL promotes inflammation","volume":"23","author":"Weichhart","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.plipres.2014.07.003_b0375","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0380","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.plipres.2014.07.003_b0385","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu171","article-title":"Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial","author":"Tardif","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.plipres.2014.07.003_b0390","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.bbalip.2007.10.001","article-title":"Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis","volume":"1771","author":"Levels","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2014.07.003_b0395","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1194\/jlr.P012518","article-title":"Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus","volume":"52","author":"Drew","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0400","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0405","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI31608","article-title":"HDL proteomics: pot of gold or Pandora\u2019s box?","volume":"117","author":"Reilly","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0410","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbalip.2012.12.015","article-title":"Distinct composition of human fetal HDL attenuates its anti-oxidative capacity","volume":"1831","author":"Sreckovic","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2014.07.003_b0415","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bbalip.2013.06.004","article-title":"Aging affects high-density lipoprotein composition and function","volume":"1831","author":"Holzer","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2014.07.003_b0420","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2011.07.013","article-title":"The HDL proteome in acute coronary syndromes shifts to an inflammatory profile","volume":"1821","author":"Alwaili","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2014.07.003_b0425","doi-asserted-by":"crossref","first-page":"e34107","DOI":"10.1371\/journal.pone.0034107","article-title":"HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography\u2013tandem mass spectrometry approach","volume":"7","author":"Mange","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2014.07.003_b0430","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/art.34363","article-title":"Proteomic profiling following immunoaffinity capture of HDL: association of acute phase proteins and complement factors with pro-inflammatory HDL in rheumatoid arthritis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.plipres.2014.07.003_b0435","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1373\/clinchem.2011.173856","article-title":"Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures","volume":"58","author":"Hoofnagle","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0440","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-511X-13-8","article-title":"The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins","volume":"13","author":"Yassine","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.plipres.2014.07.003_b0445","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.2337\/db12-1753","article-title":"The effects of type 2 diabetes on lipoprotein composition and arterial stiffness in male youth","volume":"62","author":"Gordon","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.plipres.2014.07.003_b0450","doi-asserted-by":"crossref","DOI":"10.1111\/exd.12483","article-title":"Anti-psoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function","author":"Marsche","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.plipres.2014.07.003_b0455","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(82)91362-9","article-title":"Serum amyloid A protein in high density lipoprotein fraction of human acute phase serum","volume":"2","author":"Marhaug","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2014.07.003_b0460","doi-asserted-by":"crossref","first-page":"19707","DOI":"10.1074\/jbc.M000962200","article-title":"Identification of a sequence of apolipoprotein A-I associated with the activation of lecithin: cholesterol acyltransferase","volume":"275","author":"Sviridov","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0465","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/01.ATV.19.9.2214","article-title":"Human serum paraoxonase\/arylesterase\u2019s retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity","volume":"19","author":"Sorenson","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0470","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/bi961191e","volume":"36","author":"Castro","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.plipres.2014.07.003_b0475","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1172\/JCI117614","article-title":"Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice","volume":"94","author":"Zhong","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0480","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/jid.2013.359","article-title":"Anti-psoriatic therapy recovers high-density lipoprotein composition and function","volume":"134","author":"Holzer","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.plipres.2014.07.003_b0485","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.ATV.20.3.763","article-title":"Role of serum amyloid A during metabolism of acute-phase HDL by macrophages","volume":"20","author":"Artl","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0490","doi-asserted-by":"crossref","first-page":"9644","DOI":"10.1016\/S0021-9258(18)67562-3","article-title":"Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition","volume":"261","author":"Coetzee","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0495","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2362.1996.159291.x","article-title":"Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice","volume":"26","author":"Malle","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0500","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/ATVBAHA.111.226159","article-title":"Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans","volume":"31","author":"Chiba","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0505","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1084\/jem.180.1.203","article-title":"Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes","volume":"180","author":"Badolato","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.plipres.2014.07.003_b0510","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/geno.1996.0253","article-title":"Structure of the mouse Saa4 gene and its linkage to the serum amyloid A gene family","volume":"34","author":"de Beer","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.plipres.2014.07.003_b0515","first-page":"169","article-title":"Human peripheral blood monocyte-derived macrophages produce haemolytically active C3 in vitro","volume":"49","author":"Strunk","year":"1983","journal-title":"Immunology"},{"key":"10.1016\/j.plipres.2014.07.003_b0520","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00041433-200310000-00008","article-title":"Role of complement activation in atherosclerosis","volume":"14","author":"Oksjoki","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2014.07.003_b0525","doi-asserted-by":"crossref","first-page":"18292","DOI":"10.1074\/jbc.M109.017202","article-title":"Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein","volume":"284","author":"Watanabe","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0530","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1172\/JCI109745","article-title":"Human apolipoprotein A-IV. Intestinal origin and distribution in plasma","volume":"65","author":"Green","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2014.07.003_b0535","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1016\/S0021-9258(19)39557-2","article-title":"Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV","volume":"265","author":"Goldberg","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0540","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0021-9258(18)89547-3","article-title":"Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV","volume":"260","author":"Steinmetz","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0545","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1006\/bbrc.1993.1749","article-title":"A missense mutation (Trp -->26Arg) in exon 3 of the apolipoprotein CII gene in a patient with apolipoprotein CII deficiency (apo CII-Wakayama)","volume":"193","author":"Inadera","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2014.07.003_b0550","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.ATV.19.3.472","article-title":"Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3","volume":"19","author":"Jong","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0555","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCRESAHA.108.178426","article-title":"Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation","volume":"103","author":"Kawakami","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0560","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.108.784785","article-title":"Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction","volume":"118","author":"Kawakami","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2014.07.003_b0565","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.111.000232","article-title":"Apolipoprotein C-III as a potential modulator of the association between HDL-cholesterol and incident coronary heart disease","volume":"1","author":"Jensen","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.plipres.2014.07.003_b0570","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1194\/jlr.M011163","article-title":"Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease","volume":"52","author":"Ooi","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0575","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jmb.2009.08.071","article-title":"Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M","volume":"393","author":"Sevvana","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0580","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.atherosclerosis.2011.08.049","article-title":"Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism","volume":"219","author":"Karuna","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2014.07.003_b0585","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MOL.0b013e328353c4e6","article-title":"Hyperlipidaemia and cardiovascular disease: HDL, inflammation and surprising results of AIM-HIGH study","volume":"23","author":"Nofer","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2014.07.003_b0590","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm1211","article-title":"Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis","volume":"11","author":"Wolfrum","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.plipres.2014.07.003_b0595","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1074\/jbc.M704576200","article-title":"Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice","volume":"283","author":"Christoffersen","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0600","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1357-2725(01)00155-8","article-title":"Clusterin","volume":"34","author":"Jones","year":"2002","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0605","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/ATVBAHA.110.212894","article-title":"Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia","volume":"30","author":"Hoofnagle","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0610","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trsl.2008.11.007","article-title":"Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease","volume":"153","author":"Moradi","year":"2009","journal-title":"Transl Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0615","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ki.2009.177","article-title":"In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide","volume":"76","author":"Vaziri","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.plipres.2014.07.003_b0620","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0027-9684(15)30368-0","article-title":"Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease","volume":"103","author":"Vaziri","year":"2011","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.plipres.2014.07.003_b0625","first-page":"83","article-title":"The antioxidant properties of high-density lipoproteins in atherosclerosis","volume":"54","author":"Mackness","year":"2012","journal-title":"Panminerva Med"},{"key":"10.1016\/j.plipres.2014.07.003_b0630","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MOL.0b013e3283376936","article-title":"Atherosclerosis: cell biology and lipoproteins\u2014oxidative stress and paraoxonases regulate atherogenesis","volume":"21","author":"Aviram","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2014.07.003_b0635","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.plipres.2014.07.003_b0640","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.plipres.2014.07.003_b0645","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1194\/jlr.R024190","article-title":"Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2","volume":"53","author":"Rosenson","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0650","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1016\/S0021-9258(20)71339-6","article-title":"Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II","volume":"259","author":"Cheung","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0655","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1373\/clinchem.2010.155333","article-title":"HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events","volume":"57","author":"Rosenson","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0660","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0665","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.bbalip.2013.07.009","article-title":"Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles","volume":"1831","author":"Stahlman","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plipres.2014.07.003_b0670","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/ATVBAHA.107.141747","article-title":"HDL oxidation compromises its influence on paraoxonase-1 secretion and its capacity to modulate enzyme activity","volume":"27","author":"Deakin","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2014.07.003_b0675","doi-asserted-by":"crossref","first-page":"32172","DOI":"10.1074\/jbc.M200503200","article-title":"Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport","volume":"277","author":"Marsche","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2014.07.003_b0680","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cvr\/cvn051","article-title":"Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro","volume":"79","author":"Marsche","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.plipres.2014.07.003_b0685","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1073\/pnas.0405292101","article-title":"The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport","volume":"101","author":"Bergt","year":"2004","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782714000411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782714000411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T20:00:29Z","timestamp":1649880029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782714000411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":137,"alternative-id":["S0163782714000411"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2014.07.003","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding high-density lipoprotein function in disease: Recent advances in proteomics unravel the complexity of its composition and biology","name":"articletitle","label":"Article Title"},{"value":"Progress in Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plipres.2014.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}